Cabinet appreciates positive results of international conference on Palestine co-chaired by Saudi Arabia

Saudi Crown Prince Mohammed bin Salman chairs the Cabinet session in NEOM on Tuesday. (SPA)
Short Url
Updated 05 August 2025
Follow

Cabinet appreciates positive results of international conference on Palestine co-chaired by Saudi Arabia

  • Cabinet welcomed announcements made by several participating countries of their intention to recognize the Palestinian state

RIYADH: The Cabinet on Tuesday expressed its appreciation for the positive results of the recently held High-Level International Conference for the Peaceful Settlement of the Question of Palestine and the Implementation of the Two-State Solution.

The conference, co-chaired by Saudi Arabia and France, was held between July 28-30 and aimed to catalyze concrete, time-bound, and coordinated international action toward the implementation of the two-State solution.

The chairs underlined the need to support Palestinian statehood, reinforce regional and international cooperation, and ensure respect for international law.

The Cabinet also welcomed announcements made by several participating countries of their intention to recognize the Palestinian state, Saudi Press Agency reported.

France, the UK, Canada, Portugal, Malta, and other countries have said they may recognize a State of Palestine at the UN in September.

The Cabinet reiterated the Kingdom’s call on all UN member states to support the final declaration issued by the international conference, which constitutes a comprehensive and implementable framework for implementing the two-state solution, that would in turn achieve international peace and security and contribute to building the future of the region and its peoples.

The Cabinet is following up on the Kingdom’s comprehensive support for the State of Palestine and its people, particularly on the humanitarian front, by continuing to send shelter, medical, and food aid to the Gaza Strip through the Saudi air and sea bridges.

It also condemned in the strongest terms provocative practices by Israeli government officials at Al-Aqsa Mosque, and stresses Saudi Arabia’s demand that the international community halt these practices, which violate international laws and norms.

Crown Prince Mohammed bin Salman briefed the Cabinet on the contents of letters received by King Salman and himself from the President of Azerbaijan Ilham Aliyev and his meeting with Kuwaiti Prime Minister Sheikh Ahmad Abdullah Al-Ahmad Al-Sabah.


SFDA’s generic drug conference in Riyadh to empower local pharmaceutical manufacturing

Updated 7 sec ago
Follow

SFDA’s generic drug conference in Riyadh to empower local pharmaceutical manufacturing

  • Conference aim is to build a resilient, sustainable pharmaceutical sector that supports public health

RIYADH: The Saudi Food and Drug Authority will organize the Generic Drugs Conference 2025 under the title “Empowering Local Pharmaceutical Manufacturing: The Future of Generic Drugs in Saudi Arabia” on Dec. 30 in Riyadh.

The conference aim is to build a resilient, sustainable pharmaceutical sector that supports public health, according to a press release issued by the Saudi food safety watchdog.

The conference will be a unique platform bringing together healthcare providers, regulatory experts, academics, investors, and major pharmaceutical companies to foster open dialogue, share global best practices, and align efforts toward strengthening the generic drug sector in Saudi Arabia.

Bringing together a distinguished group of experts, leaders, regulators, healthcare professionals and pharmaceutical industry leaders, the conference will discuss the latest developments, challenges, and opportunities in the field of generic medicines.

With discussion sessions, interactive dialogues and numerous networking opportunities, the conference opens new horizons to enhance collaboration, innovation, and sustainable growth in the generic medicines sector, supporting improved access to medicines and raising their quality.

The conference agenda is designed to address strategic themes, including national efforts to enhance drug security; investment and regulatory enablers for generic drug manufacturing; pharmaceutical research and development and formulation challenges; pricing, reimbursement, and market access policies; and supply chain resilience and good manufacturing practice compliance, all aimed at strengthening public confidence in generics.

The conference, designed for professionals and stakeholders involved in the development, regulation, manufacturing, and distribution of generic and biosimilar medicines, comes at a pivotal time in Saudi Arabia’s healthcare and pharmaceutical sectors.

With Saudi Vision 2030 driving economic diversification and healthcare transformation, the local pharmaceutical industry is a cornerstone of national drug security, public health sustainability, and economic growth.